{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T14:40:26Z","timestamp":1684593626170},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s11920-008-0060-z","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T06:17:32Z","timestamp":1224137852000},"page":"375-376","source":"Crossref","is-referenced-by-count":0,"title":["Preserved DNA from past clinical trials yields new information about a subtype of alcoholism"],"prefix":"10.1007","volume":"10","author":[{"given":"Charles P.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,17]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0024-3205(80)90257-X","volume":"26","author":"H.L. Altshuler","year":"1980","unstructured":"Altshuler HL, Phillips PA, Feinhandler DA: Alteration of ethanol self-administration by naltrexone. Life Sci 1980, 26: 679\u2013688.","journal-title":"Life Sci"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"J.R. Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O\u2019Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992, 49: 876\u2013880.","journal-title":"Arch Gen Psychiatry"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"S.S. O\u2019Malley","year":"1992","unstructured":"O\u2019Malley SS, Jaffe AJ, Chang G, et al.: Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992, 49: 881\u2013887.","journal-title":"Arch Gen Psychiatry"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.jcp.0000245566.52401.20","volume":"26","author":"H.M. Pettinati","year":"2006","unstructured":"Pettinati HM, O\u2019Brien CP, Rabinowitz AR, et al.: The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol 2006, 26: 610\u2013625.","journal-title":"J Clin Psychopharmacol"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1523\/JNEUROSCI.18-24-10663.1998","volume":"18","author":"R.A. Gonzales","year":"1998","unstructured":"Gonzales RA, Weiss F: Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 1998, 18: 10663\u201310671.","journal-title":"J Neurosci"},{"key":"60_CR6","first-page":"304","volume":"26","author":"C. Gianoulakis","year":"2001","unstructured":"Gianoulakis C: Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci 2001, 26: 304\u2013318.","journal-title":"J Psychiatry Neurosci"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130050156","volume":"129","author":"A. King","year":"1997","unstructured":"King A, Volpicelli J, Frazer A, O\u2019Brien C: Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 1997, 129: 15\u201322.","journal-title":"Psychopharmacology"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","volume":"30","author":"G. Bart","year":"2005","unstructured":"Bart G, Kreek MJ, Ott J, et al.: Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2005, 30: 417\u2013422.","journal-title":"Neuropsychopharmacology"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.10054","volume":"118B","author":"C.A. Hernandez-Avila","year":"2003","unstructured":"Hernandez-Avila CA, Wand G, Luo X, et al.: Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 2003, 118B: 60\u201365.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C. Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M, et al.: Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 1998, 95: 9608\u20139613.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"60_CR11","doi-asserted-by":"crossref","unstructured":"Ray L, Hutchison K: A double-blind placebo-controlled study of the effects of naltrexone on alcohol sensitivity and genetic moderators of medication response. Arch Gen Psychiatry 2008 (in press).","DOI":"10.1001\/archpsyc.64.9.1069"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"R. Anton","year":"2006","unstructured":"Anton R, O\u2019Malley S, Ciraulo D, et al.: Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE Study: a randomized controlled trial. JAMA 2006, 295: 2003\u20132007.","journal-title":"JAMA"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","volume":"31","author":"J. Gelernter","year":"2007","unstructured":"Gelernter J, Gueorguieva R, Kranzler HR, et al.: Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 2007, 31: 555\u2013563.","journal-title":"Alcohol Clin Exp Res"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1530-0277.2008.00735.x","volume":"32","author":"A.J. Arias","year":"2008","unstructured":"Arias AJ, Armeli S, Gelernter J, et al.: Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. Alcohol Clin Exp Res 2008, 32: 1159\u20131166.","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-008-0060-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-008-0060-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-008-0060-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T14:02:34Z","timestamp":1684591354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-008-0060-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11920-008-0060-z","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}